[1]
W. Zahoor, “EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & −191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA”, Exp. oncol., vol. 45, no. 2, pp. 203–210, Oct. 2023.